Tenax Therapeutics (TENX) Other Accumulated Expenses (2015 - 2024)
Tenax Therapeutics (TENX) reported Other Accumulated Expenses of $105823.0 for Q3 2024, down 56.9% on a YoY basis from $245545.0 in Q4 2023, and down 34.1% sequentially from $160581.0 in Q2 2024.
Tenax Therapeutics (TENX) Other Accumulated Expenses (2015 - 2024) Analysis & Trends
Tenax Therapeutics (TENX) has 10 years of Other Accumulated Expenses data on file, last reported at $105823.0 in Q3 2024.
- For the quarter ending Q3 2024, Other Accumulated Expenses fell 56.9% year-over-year to $105823.0; the trailing twelve-month figure through Sep 2024 stood at $105823.0 (down 56.9% YoY), and the FY2023 full-year result was $236878.0, down 3.47% from the prior year.
- Other Accumulated Expenses fell to $105823.0 in Q3 2024, from $160581.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $503023.0 in Q1 2020 to a low of $84595.0 in Q1 2021.
- A 5-year average of $223434.9 and a median of $238206.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses slumped 86.03% in 2020 and soared 208.98% in 2022, its largest moves.
- Tracing TENX's Other Accumulated Expenses over 5 years: stood at $319608.0 in 2020, then tumbled by 62.96% to $118372.0 in 2021, then jumped by 107.3% to $245391.0 in 2022, then slipped by 3.47% to $236878.0 in 2023, then plunged by 55.33% to $105823.0 in 2024.
- Business Quant data shows TENX's Other Accumulated Expenses at $105823.0 in Q3 2024, $160581.0 in Q2 2024, and $253517.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 105,823.00 |
| Jun 30, 2024 | 160,581.00 |
| Mar 31, 2024 | 253,517.00 |
| Dec 31, 2023 | 236,878.00 |
| Sep 30, 2023 | 245,545.00 |
| Jun 30, 2023 | 230,000.00 |
| Mar 31, 2023 | 246,766.00 |
| Dec 31, 2022 | 245,391.00 |
| Sep 30, 2022 | 230,480.00 |
| Jun 30, 2022 | 239,534.00 |
| Mar 31, 2022 | 261,384.00 |
| Sep 30, 2021 | 118,372.00 |
| Jun 30, 2021 | 154,051.00 |
| Mar 31, 2021 | 84,595.00 |
| Dec 31, 2020 | 319,608.00 |
| Sep 30, 2020 | 100,932.00 |
| Jun 30, 2020 | 285,348.00 |
| Mar 31, 2020 | 503,023.00 |
| Dec 31, 2019 | 426,115.00 |
| Sep 30, 2019 | 722,624.00 |